Behavioral and Cognitive Outcomes for Clinical Trials in Children With Neurofibromatosis Type 1

Neurology - United States
doi 10.1212/wnl.0000000000002118
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Neurocognitive Outcomes in Neurofibromatosis Clinical Trials

Neurology
Neurology
2016English

Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1

JAMA - Journal of the American Medical Association
Medicine
2008English

Health Supervision for Children With Neurofibromatosis Type 1

Pediatrics
Child HealthPediatricsPerinatology
2019English

Cognitive and Psychosocial Phenotype of Young Children With Neurofibromatosis-1

Journal of the International Neuropsychological Society
PsychiatryClinical PsychologyMental HealthNeurologyNeuroscience
2013English

Clinical Manifestations of Neurofibromatosis Type 1

Endocrine Abstracts
2014English

Optimizing Biologically Targeted Clinical Trials for Neurofibromatosis

Expert Opinion on Investigational Drugs
MedicinePharmacology
2013English

Neurocognitive Profiles of Learning Disabled Children With Neurofibromatosis Type 1

Frontiers in Human Neuroscience
Mental HealthNeuropsychologyPhysiological PsychologyNeurologyBehavioral NeurosciencePsychiatryBiological Psychiatry
2014English

Exploring the Genetic Basis for Clinical Variation in Neurofibromatosis Type 1

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2016English

Cognitive Profile of Children With Neurofibromatosis and Reading Disabilities

Child Neuropsychology
DevelopmentalChild HealthNeuropsychologyEducational PsychologyPhysiological PsychologyPerinatologyPediatrics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy